Riccardo Castelli
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Iso- and Benzisothiazolinone Inhibitors of Monoacylglycerol Lipase: Exploring On-Target Activity Through Scaffold Decoration and In Situ Warhead Generation.
Journal: ChemMedChem
Published: May 26, 2026
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors.
Journal: Biochemical pharmacology
Published: December 18, 2025
Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 23, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2025
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication.
Journal: Biochemical pharmacology
Published: May 29, 2025
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line.
Journal: European journal of medicinal chemistry
Published: February 26, 2024
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.
Journal: ACS chemical neuroscience
Published: February 19, 2024
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity.
Journal: Pharmacological research
Published: December 20, 2023
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity.
Journal: Journal of chemical information and modeling
Published: November 01, 2023
A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 29, 2023
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors.
Journal: European journal of medicinal chemistry
Published: July 27, 2022
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 23, 2021
Last Updated: 09/26/2026